Neither medicine is always better than the other
Study findings revealed that, despite early concerns and warnings related to specific cancer types, the bulk of evidence from large-scale meta-analyses does not show an increased cancer incidence
Evidence published in journals such as The Lancet and JAMA indicates that Wegovy, when combined with lifestyle changes, can support meaningful and sustained weight reduction
Understanding these risks is crucial for making an informed decision about starting treatment
There are many different types of medications, most of which are geared towards altering our hormones, and that can help with the bleeding patterns and sometimes shrink those fibroids
A study published in the New England Journal of Medicine found that semaglutide, the active ingredient in Ozempic and WeGovy, was more effective in promoting weight loss than Saxemda (liraglutide) in people with type 2 diabetes